Search results for "Tributi"

showing 10 items of 6415 documents

How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire.

2008

We used a CAPSIT-based questionnaire to estimate the percentage of parkinsonian patients suitable for subthalamic nucleus (STN) deep brain stimulation (DBS) in a movement disorders clinic. We found that out of 641 consecutive PD patients only 1.6% fulfilled strict STN-DBS criteria. When we applied more flexible criteria, the percentage of eligibility increased to 4.5%. Most patients (60%) were ineligible because they did not satisfy multiple questionnaire items. Items related to disease severity were responsible for the largest number of exclusions. This knowledge will help make decisions on resource allocation in centres wishing to start DBS surgery.

AdultMalemedicine.medical_specialtyParkinson's diseaseMovement disordersNeurologyDeep brain stimulationDeep Brain Stimulationmedicine.medical_treatmentParkinson Desease Deep Brain StimulationAudiologybehavioral disciplines and activitiesDisease severityParkinsonian DisordersSubthalamic NucleusSurveys and QuestionnairesmedicineHumansAgedChi-Square Distributionbusiness.industryPatient SelectionMiddle Agedmedicine.diseasenervous system diseasesSubthalamic nucleussurgical procedures operativenervous systemNeurologyCAPSIT; Parkinson's disease; Questionnaire; STN DBS; Adult; Aged; Chi-Square Distribution; Deep Brain Stimulation; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Subthalamic Nucleus; Surveys and Questionnaires; Patient Selection; Aging; Neurology (clinical); NeurologyPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomGeriatrics and GerontologyPsychologybusinesstherapeuticsNeuroscienceNeurology; Geriatrics and Gerontology; Neurology (clinical)
researchProduct

Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States

2016

Objectives Survival improvement for pancreatic cancer has not been observed in the last 4 decades. We report the most up-to-date population-based relative survival (RS) estimates and recent trends in Germany and the United States. Methods Data for patients diagnosed in 1997 to 2010 and followed up to 2010 were drawn from 12 population-based German cancer registries and the US SEER (Surveillance, Epidemiology and End Results) 13 registries database. Using period analysis, 5-year RS for 2007 to 2010 was derived. Model-based period analysis was used to assess 5-year RS time trends, 2002-2010. Results In total 28,977 (Germany) and 34,793 (United States) patients aged 15 to 74 years were analyze…

AdultMalemedicine.medical_specialtyPathologyAdolescentEndocrinology Diabetes and MetabolismPopulationYoung Adult03 medical and health sciencesAge DistributionSex Factors0302 clinical medicineEndocrinologyGermanyPancreatic cancerEpidemiologyInternal MedicineHumansMedicineRegistriesYoung adulteducationSurvival analysisAgedNeoplasm StagingAged 80 and overeducation.field_of_studyHepatologyRelative survivalbusiness.industryAge FactorsCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUnited StatesPancreatic NeoplasmsSurvival Rate030220 oncology & carcinogenesisPeriod AnalysisFemale030211 gastroenterology & hepatologybusinessSEER ProgramDemographyPancreas
researchProduct

A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.

2015

Objective: Qualitative capillaroscopy patterns in juvenile- and adult-onset systemic sclerosis (SSc) were studied in adulthood using data from the EULAR Scleroderma Trials and Research (EUSTAR) database. Methods: Data collected between June 2004 and April 2013 were examined with focus on capillaroscopy. In this retrospective exploratory study, series of patients with juvenile-onset SSc were matched with series of adult-onset SSc having the same gender and autoantibody profile. Results: 30 of 123 patients with juvenile-onset and 2108 of 7133 with adult-onset SSc had data on capillaroscopy. Juvenile-onset SSc showed scleroderma pattern more frequently than adult-onset SSc (93.3% and 88%). The…

AdultMalemedicine.medical_specialtyPathologyAdolescentKlinikai orvostudományokBiochemistryJuvenile systemic sclerosiSclerodermaMicroscopic AngioscopySystemic sclerosiScleroderma LocalizedYoung AdultMedicineJuvenileHumansYoung adultAge of Onsetskin and connective tissue diseasesChildNailfold CapillaroscopyVideocapillaroscopyAgedRetrospective StudiesEUSTARScleroderma Systemicintegumentary systemCapillaroscopybusiness.industrySimilar distributionMicrocirculationAutoantibodyRetrospective cohort studyOrvostudományokCell BiologyMiddle Agedmedicine.diseaseDermatologyCapillariesNailfold capillaroscopyFemaleAge of onsetCardiology and Cardiovascular MedicinebusinessCapillaroscopy; EUSTAR; Juvenile systemic sclerosis; Microcirculation; Nailfold capillaroscopy; Systemic sclerosis; Videocapillaroscopy; Biochemistry; Cardiology and Cardiovascular Medicine; Cell BiologyMicrovascular research
researchProduct

Assessing age and gender in studies of breakthrough pain medications

2014

AbstractObjective:The present review was performed to identify possible differences observed between adults and elderly patients and between males and females in randomized clinical trials of breakthrough pain (BTP).Methods:A systematic search of the existing literature from 1998 to September 2013 was performed. Randomized clinical trials reporting data on older patients were selected.Results:Sixteen comparative studies were selected. The age range of inclusion criteria patients was mainly between 18–80 or ≥18 years. In some cases this data was unreported. The mean age of patients was 48–64 years, but information regarding the number of elderly patients was present in three studies only. Ge…

AdultMalemedicine.medical_specialtyPediatricsBreakthrough PainSubgroup analysislaw.inventionAge and genderSex FactorsRandomized controlled trialOlder patientslawNeoplasmsmedicineHumansPsychiatryAdverse effectAgedRandomized Controlled Trials as Topicbusiness.industryBreakthrough PainAge FactorsGender distributionGeneral Medicinebreakthrough pain cancer painAnalgesics OpioidTreatment OutcomeFemaleCancer painbusinessCurrent Medical Research and Opinion
researchProduct

Prevalence of tension-type headache in adult general population: the PACE study and review of the literature

2013

The mean global prevalence of tension-type headache (TTH) in adult is 42 %. To date, there have been no Italian studies on TTH prevalence in the adult general population. Therefore, we conducted a cross-sectional study, called PACE (PArma CEfalea, or "Headache in Parma"), aimed at detecting the prevalence and clinical features of primary headaches in the city of Parma's adult general population. Crude past-year prevalence for definite TTH was 19.4 % (95 % CI 16.8-21.9), namely 9.0 % (95 % CI 7.1-10.8) for infrequent TTH, 9.8 % (95 % CI 7.9-11.8) for frequent TTH, and 0.6 % (95 % CI 0.1-1) for chronic TTH. Crude prevalence for probable TTH was 2.3 % (95 % CI 1.3-3.3). Our study results indic…

AdultMalemedicine.medical_specialtyPediatricsCross-sectional studyPopulationPrevalenceDermatologyHeadache Tension-type headache Past-year prevalence Epidemiology ReviewLower limitAge DistributionPrimary headacheEpidemiologyPrevalencemedicineHumanseducationAgededucation.field_of_studybusiness.industryTension-Type HeadacheGeneral MedicineMiddle AgedPsychiatry and Mental healthCross-Sectional StudiesItalySettore MED/26 - NeurologiaFemaleAge distributionNeurology (clinical)businessNeurological Sciences
researchProduct

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.

2006

1. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1117-25. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Prantera C, Lochs H, Campieri M, Scribano ML, Sturniolo GC, Castiglione F, Cottone M. Operative Unit of Gastroenterology, St Camillo-Forlanini Hospital, Rome, Italy. prantera@tin.it BACKGROUND: Clinicians often employ antibiotics in Crohn's disease. Rifaximin is active against bacteria frequently found in the intestinal mucosa of Crohn's disease patients. AIM: To evaluate the difference in efficacy between once and twice/daily oral administration of rifaximin and placebo in the treatment of active Crohn's …

AdultMalemedicine.medical_specialtyPlacebo-controlled studyCIPROFLOXACINPlaceboGastroenterologyInflammatory bowel diseaseDrug Administration ScheduleRifaximinPlaceboschemistry.chemical_compoundCrohn DiseaseDouble-Blind MethodIntestinal mucosaINFLAMMATORY-BOWEL-DISEASE C-REACTIVE PROTEIN ULCERATIVE-COLITIS METRONIDAZOLE CIPROFLOXACIN MANAGEMENT RECURRENCE DIARRHEA ANTIBODY MODERATEInternal medicinemedicineMANAGEMENTHumansPharmacology (medical)RECURRENCEAntibacterial agentCrohn's diseaseChi-Square DistributionHepatologybusiness.industryGastroenterologyMiddle Agedmedicine.diseaseRifamycinsUlcerative colitisDIARRHEAC-REACTIVE PROTEINAnti-Bacterial AgentsSurgeryRifaximinTreatment OutcomechemistryULCERATIVE-COLITISANTIBODYMETRONIDAZOLEAcute Diseaserifaximin.crohn's diseaseMODERATEFemalebusinessINFLAMMATORY-BOWEL-DISEASE
researchProduct

Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: Data from the German CVSS-study.

2018

Aims: The cardiac and vascular late sequelae in long-term survivors of childhood cancer (CVSS)-study aimed to quantify the prevalence of cardiovascular risk factors (CVRF) and cardiovascular disease (CVD) in German childhood cancer survivors (CCS). Methods and results: In the CVSS-study (NCT02181049), 1002 CCS (age range 23-48 years) diagnosed with neoplasia prior to 15 years of age between 1980 and 1990 prospectively underwent a systematic, standardized clinical and laboratory cardiovascular screening, identical to the population-based Gutenberg Health Study (GHS) cohort. For 951 individuals, prevalences of CVRF and CVD were primarily compared to the GHS sample and to two further German po…

AdultMalemedicine.medical_specialtyPopulationComorbidity030204 cardiovascular system & hematologyYoung Adult03 medical and health sciences0302 clinical medicineCancer SurvivorsRisk FactorsGermanyDiabetes mellitusInternal medicineDiabetes MellitusPrevalenceHumansMedicineObesityAge of OnsetSex DistributionYoung adulteducationeducation.field_of_studybusiness.industrySmokingMiddle Agedmedicine.diseaseComorbidityConfidence intervalCardiotoxicity ; Long-term Survivors ; Late Sequelae ; Cardiovascular Morbidity ; Cardio-oncologyCardiovascular Diseases030220 oncology & carcinogenesisRelative riskCohortFemaleAge of onsetCardiology and Cardiovascular Medicinebusiness
researchProduct

Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects. The Casteldaccia Eye Study

2003

PURPOSE: To investigate the prevalence and risk factors of diabetic retinopathy in subjects aged 40 years or older living in Casteldaccia, Sicily. METHODS: A population-based survey was performed on 1,588 subjects randomly enrolled among people aged 40 years or older. A total of 1,068 persons could be examined and in 1,019 the fundus of the eye was adequately observed (64.2% of the enrolled population). Diabetic retinopathy was diagnosed by ophthalmoscopy and fundus photographs; fluorescein angiography was performed in 91% of retinopathic subjects. In addition, a case-control study was carried out in order to demonstrate the association of diabetic retinopathy with a number of variables. RE…

AdultMalemedicine.medical_specialtyPopulationFundus (eye)OphthalmoscopyCellular and Molecular NeuroscienceAge DistributionRisk FactorsInternal medicineDiabetes mellitusPrevalenceHumansMedicineSex DistributionRisk factoreducationSicilyAgededucation.field_of_studyDiabetic Retinopathymedicine.diagnostic_testbusiness.industryDiabetic Retinopathy Fluorescein Angiography Proliferative Diabetic Retinopathy Fundus Photograph Antidiabetic TreatmentCase-control studyDiabetic retinopathyMiddle Agedmedicine.diseaseFluorescein angiographyHealth SurveysSensory SystemsSurgeryOphthalmologyCase-Control StudiesFemalebusiness
researchProduct

Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in hi…

2006

Objective To compare outcome parameters and cumulative pregnancy rates (PRs) in oocyte donation cycles over a period of 10 years. Design Retrospective study. Setting University-affiliated assisted reproductive technology program. Patient(s) Women undergoing oocyte donation (10,537 cycles) between 1995 and 2005. Intervention(s) Ovarian stimulation and oocyte retrieval in donors. Embryo transfer performed in recipients after endometrial preparation. Main Outcome Measure(s) Outcome parameters and cumulative PRs were calculated and compared in relation to indication, age, and origin of sperm used. Result(s) Overall PR, implantation rate, clinical PR, and miscarriage rate per embryo transfer per…

AdultMalemedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentBiologyInseminationMiscarriageAge DistributionPregnancymedicineHumansEmbryo ImplantationRetrospective StudiesGynecologyPregnancyAssisted reproductive technologyOocyte DonationObstetricsObstetrics and GynecologyMiddle AgedOocytemedicine.diseaseSpermEmbryo transferPregnancy ratemedicine.anatomical_structureReproductive MedicineFemalePregnancy MultipleFertility and Sterility
researchProduct

Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication.

2011

Objective To demonstrate that the use of donor sperm leads to varying outcome rates and that its use has evolved. Design Retrospective observational cohort study. Setting University-affiliated private IVF setting. Patient(s) Women (2,934) undergoing donor insemination (DI) or IVF with donor sperm (IVF-D). Intervention(s) None. Main Outcome Measurement(s) We evaluated the distribution of the clinical indications for the use of donated sperm, studying the reproductive outcome. Result(s) A total of 1,663 DI (57%) and 1,271 IVF-D (43%) were performed. There were significant differences in the indications for the use of donated sperm (DI vs. IVF-D). Regarding pregnancy rates (PR), cases of nonob…

AdultMalemedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentPopulationFertilization in VitroBiologyRisk AssessmentIntracytoplasmic sperm injectionPregnancyRisk FactorsmedicineOdds RatioHumansAdvanced maternal ageSperm Injections Intracytoplasmiceducationreproductive and urinary physiologyAzoospermiaRetrospective StudiesGynecologyPregnancyeducation.field_of_studyIn vitro fertilisationChi-Square Distributionurogenital systemObstetricsObstetrics and GynecologySingle Personmedicine.diseaseSpermSpermatozoaTissue DonorsLogistic ModelsTreatment OutcomeReproductive MedicineSpainInsemination Artificial HeterologousFemaleDonor spermCohort studyMaternal AgeFertility and sterility
researchProduct